[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Regeneron Pharmaceuticals Stock: Is REGN Outperforming the Healthcare Sector?

Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company has a market capitalization of $82.3 billion and develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases, as well as cancer and more.

Companies with a market cap of $10 billion or more are typically referred to as “large-cap stocks.” REGN fits squarely into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the biotechnology industry.  

However, the stock currently trades 37.1% below its 52-week...

Fundamentals

See More
  • Market Capitalization, $K 84,816,392
  • Shares Outstanding, K 102,955
  • Annual Sales, $ 14,343 M
  • Annual Income, $ 4,505 M
  • EBIT $ 3,843 M
  • EBITDA $ 4,387 M
  • 60-Month Beta 0.19
  • Price/Sales 5.74
  • Price/Cash Flow 18.92
  • Price/Book 2.58

Options Overview Details

View History
  • Implied Volatility 27.71% (+0.66%)
  • Historical Volatility 28.85%
  • IV Percentile 7%
  • IV Rank 7.58%
  • IV High 49.01% on 10/10/25
  • IV Low 25.96% on 08/14/26
  • Expected Move (DTE 2) 7.57 (0.92%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 635
  • Volume Avg (30-Day) 1,405
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 37,421
  • Open Int (30-Day) 39,680
  • Expected Range 816.26 to 831.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $12.89
  • Number of Estimates 6
  • High Estimate $15.06
  • Low Estimate $9.58
  • Prior Year $9.63
  • Growth Rate Est. (year over year) +33.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
747.00 +11.52%
on 08/04/26
847.00 -1.65%
on 08/21/26
+70.43 (+9.24%)
since 07/31/26
3-Month
594.90 +40.03%
on 06/22/26
847.00 -1.65%
on 08/21/26
+230.14 (+38.17%)
since 06/02/26
52-Week
541.00 +53.99%
on 10/13/25
847.00 -1.65%
on 08/21/26
+255.16 (+44.15%)
since 09/02/25

Most Recent Stories

More News
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN)

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or...

REGN : 833.06 (+1.12%)
Regeneron Pharmaceuticals Stock: Is REGN Outperforming the Healthcare Sector?

Regeneron Pharmaceuticals has outpaced the healthcare sector, and analysts remain moderately optimistic about the stock’s outlook.

XLV : 172.44 (+0.45%)
VRTX : 547.65 (+0.57%)
REGN : 833.06 (+1.12%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN

NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ:...

REGN : 833.06 (+1.12%)
Portnoy Law Firm Announces Class Action on Behalf of Regeneron Pharmaceuticals, Inc. Investors

LOS ANGELES, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals, Inc., (“Regeneron” or the "Company") (NASDAQ: REGN) investors of a class action on behalf...

REGN : 833.06 (+1.12%)
INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. (REGN) Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit Before September 14, 2026 Deadline

SAN FRANCISCO , Sept. 1, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN)  that a securities class action lawsuit has been filed...

REGN : 833.06 (+1.12%)
Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 14, 2026 Lead Plaintiff Deadline

SAN FRANCISCO , Aug. 28, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN)  that a securities class action lawsuit has been filed...

REGN : 833.06 (+1.12%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN

NEW YORK , Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN). Such...

REGN : 833.06 (+1.12%)
REGN DEADLINE: SueWallSt Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline

Control-person liability allegations focus on Regeneron executives' alleged authority over public clinical-trial statements and SEC disclosures as REGN shares fell $102.09 from the Class Period...

REGN : 833.06 (+1.12%)
Regeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

SAN FRANCISCO , Aug. 26, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN)  that a securities class action lawsuit has been filed...

REGN : 833.06 (+1.12%)
Robbins LLP Reminds REGN Stockholders of the Pending Lead Plaintiff Deadline in the Class Action Against Regeneron Pharmaceuticals, Inc.

San Diego, California--(Newsfile Corp. - August 26, 2026) - Robbins LLP reminds investors that a securities class action has been filed on behalf of investors who purchased or otherwise acquired Regeneron...

REGN : 833.06 (+1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also...

See More

Key Turning Points

3rd Resistance Point 851.17
2nd Resistance Point 837.90
1st Resistance Point 830.86
Last Price 833.06
1st Support Level 810.55
2nd Support Level 797.28
3rd Support Level 790.24

See More

52-Week High 847.00
Last Price 833.06
Fibonacci 61.8% 730.11
Fibonacci 50% 694.00
Fibonacci 38.2% 657.89
52-Week Low 541.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.